Is adiposopathy (sick fat) an endocrine disease?

World Health Organization Global Strategy on Diet, Physical Activity and Health http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/ 2008

Bays, 2007, The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys, Int J Clin Pract, 61, 737, 10.1111/j.1742-1241.2007.01336.x

Bays, 2008, Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Rev Cardiovasc Ther, 3, 343, 10.1586/14779072.6.3.343

Karelis, 2004, Metabolic and body composition factors in subgroups of obesity: what do we know?, J Clin Endocrinol Metab, 89, 2569, 10.1210/jc.2004-0165

Bays, 2006, Adiposopathy is a more rational treatment target for metabolic disease than obesity alone, Curr Atheroscler Rep, 8, 144, 10.1007/s11883-006-0052-6

Bays, 2006, Adiposopathy: why do adiposity and obesity cause metabolic disease?, Future Lipidol, 1, 389, 10.2217/17460875.1.4.389

Bays, 2007, Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk, Curr Treat Options Cardiovasc Med, 9, 259, 10.1007/s11936-007-0021-6

Bays, 2006, Adiposopathy: how do diet, exercise, weight loss and drug therapies improve metabolic disease?, Expert Rev Cardiovasc Ther, 4, 871, 10.1586/14779072.4.6.871

Bays, 2005, Adiposopathy: sick fat causes high blood sugar, high blood pressure, and dyslipidemia, Future Cardiol, 1, 39, 10.1517/14796678.1.1.39

Bray, 1977, Spontaneous and experimental human obesity: effects of diet and adipose cell size on lipolysis and lipogenesis, Metabolism, 26, 739, 10.1016/0026-0495(77)90061-0

Weyer, 2000, Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance, Diabetologia, 43, 1498, 10.1007/s001250051560

Kelley, 2000, Fuel selection in human skeletal muscle in insulin resistance: a re-examination, Diabetes, 49, 677, 10.2337/diabetes.49.5.677

Bays, 2004, Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach, J Clin Endocrinol Metab, 89, 463, 10.1210/jc.2003-030723

Nadler, 2000, The expression of adipogenic genes is decreased in obesity and diabetes mellitus, Proc Natl Acad Sci USA, 97, 11371, 10.1073/pnas.97.21.11371

Heilbronn, 2004, Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus, Int J Obes Relat Metab Disor, 28, S12, 10.1038/sj.ijo.0802853

Ravussin, 2002, Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus, Ann NY Acad Sci, 967, 363, 10.1111/j.1749-6632.2002.tb04292.x

Karlsson, 1998, Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II, J Clin Endocrinol Metab, 83, 3925

Hegele, 2004, Unbuckling lipodystrophy from insulin resistance and hypertension, J Clin Invest, 114, 163, 10.1172/JCI200422382

Lee, 2003, Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1), J Clin Invest, 111, 453, 10.1172/JCI15924

Salans, 1974, Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effects of dietary composition and adipose cell size, J Clin Invest, 53, 848, 10.1172/JCI107625

Haller, 1979, Relationship between adipocyte hypertrophy and metabolic disturbances, Endokrinologie, 74, 63

Pausova, 2006, From big fat cells to high blood pressure: a pathway to obesity-associated hypertension, Curr Opin Nephrol Hypertens, 15, 173, 10.1097/01.mnh.0000214775.42103.a5

Ehrhart-Bornstein, 2003, Human adipocytes secrete mineralocorticoid-releasing factors, Proc Natl Acad Sci USA, 100, 14211, 10.1073/pnas.2336140100

Blouin, 2005, Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women, Am J Physiol Endocrinol Metab, 288, E398, 10.1152/ajpendo.00312.2004

Arsenault, 2007, Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome, Arch Intern Med, 167, 1518, 10.1001/archinte.167.14.1518

Rader, 2007, Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus, Am J Med, 120, S12, 10.1016/j.amjmed.2007.01.003

Hayashi, 2004, Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans, Ann Intern Med, 140, 992, 10.7326/0003-4819-140-12-200406150-00008

Hall, 2003, Obesity-associated hypertension and kidney disease, Curr Opin Nephrol Hypertens, 12, 195, 10.1097/00041552-200303000-00011

Wilding, 2007, The importance of free fatty acids in the development of type 2 diabetes, Diabet Med, 24, 934, 10.1111/j.1464-5491.2007.02186.x

Sarafidis, 2007, Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?, J Hum Hypertens, 21, 12, 10.1038/sj.jhh.1002103

Fagot-Campagna, 1998, High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study, Int J Epidemiol, 27, 808, 10.1093/ije/27.5.808

Koutsari, 2006, Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity, J Lipid Res, 47, 1643, 10.1194/jlr.R600011-JLR200

Kershaw, 2004, Adipose tissue as an endocrine organ, J Clin Endocrinol Metab, 89, 2548, 10.1210/jc.2004-0395

Lenz, 2008, Obesity: the hormonal milieu, Curr opin Endocrinol Diabetes Obes, 15, 9, 10.1097/MED.0b013e3282f43a5b

Mukherjee, 2005, Leptin as a common link to obesity and hypertension, Drugs Today (Barc), 41, 687, 10.1358/dot.2005.41.10.899612

Antuna-Puente, 2008, Adipokines: the missing link between insulin resistance and obesity, Diabetes Metab, 1, 2, 10.1016/j.diabet.2007.09.004

Calabro, 2007, Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ, Subcell Biochem, 42, 63, 10.1007/1-4020-5688-5_3

Trayhurn, 2005, Signalling role of adipose tissue: adipokines and inflammation in obesity, Biochem Coc Trans, 33, 1078, 10.1042/BST0331078

Pauletto, 2006, Inflammation and hypertension: the search for a link, Nephrol Dial Transplant, 21, 850, 10.1093/ndt/gfl019

Chudek, 2006, Adipose tissue, inflammation and endothelial dysfunction, Pharmacol Rep, 58, 81

Yu, 2005, Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue, Circ Res, 96, 1042, 10.1161/01.RES.0000165803.47776.38

Tomas, 2004, Metabolic and hormonal interactions between muscle and adipose tissue, Proc Nutr Soc, 63, 381, 10.1079/PNS2004356

Bays, 2007, Adiposopathy: the endocannabinoid system as a therapeutic treatment target for dysfunctional ‘sick’ fat, Californian J Health Promot, 19, 32

Rumantir, 1999, Neural mechanisms in human obesity-related hypertension, J Hypertens, 17, 1125, 10.1097/00004872-199917080-00012

Altman, 2002, Weight in the balance, Neuroendocrinology, 76, 131, 10.1159/000064528

Schling, 2002, Cross talk between adipose tissue cells: impact on pathophysiology, News Physiol Sci, 17, 99

Storlien, 2004, Metabolic flexibility, Proc Nutr Soc, 63, 363, 10.1079/PNS2004349

Schaffler, 2006, Role of adipose tissue as an inflammatory organ in human diseases, Endocr Rev, 27, 449, 10.1210/er.2005-0022

Flegal, 2007, Cause-specific excess deaths associated with underweight, overweight, and obesity, JAMA, 298, 2028, 10.1001/jama.298.17.2028

Uretsky, 2007, Obesity paradox in patients with hypertension and coronary artery disease, Am J Med, 120, 863, 10.1016/j.amjmed.2007.05.011

Tchoukalova, 2008, Subcutaneous adipocyte size and body fat distribution, Am J Clin Nutr, 87, 56, 10.1093/ajcn/87.1.56

Vague, 1947, La differenciation sexuelle, facteur determinant des formes de l’obesite, Presse Med, 30, 339

Tchkonia, 2007, Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns, Am J Physiol Endocrinol Metab, 292, E298, 10.1152/ajpendo.00202.2006

Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/edrv.21.6.0415

Baker, 2006, Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease, Cardiovasc Diabetol, 5, 1, 10.1186/1475-2840-5-1

Higuchi, 2002, Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries, Arq Bras Cardiol, 79, 20, 10.1590/S0066-782X2002001000003

Mazurek, 2003, Human epicardial adipose tissue is a source of inflammatory mediators, Circulation, 108, 2460, 10.1161/01.CIR.0000099542.57313.C5

Engeli, 2005, Is there a pathophysiological role for perivascular adipocytes?, Am J Physiol Heart Circ Physiol, 289, H1794, 10.1152/ajpheart.00762.2005

Imbeault, 1999, Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?, Metabolism, 48, 355, 10.1016/S0026-0495(99)90085-9

Van Harmelen, 1998, Leptin secretion from subcutaneous and visceral adipose tissue in women, Diabetes, 47, 913, 10.2337/diabetes.47.6.913

Couillard, 2000, Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia, Int J Obes Relat Metab Disord, 24, 782, 10.1038/sj.ijo.0801227

Franks, 2005, Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity, Obes Res, 13, 1476, 10.1038/oby.2005.178

Bravo, 2006, Leptin and hypertension in obesity, Vasc Health Risk Manag, 2, 163, 10.2147/vhrm.2006.2.2.163

Acree, 2007, The influence of obesity on arterial compliance in adult men and women, Vasc Med, 12, 183, 10.1177/1358863X07079323

Johnson, 2001, Impaired insulin action in subcutaneous adipocytes from women with visceral obesity, Am J Physiol Endocrinol Metab, 280, E40, 10.1152/ajpendo.2001.280.1.E40

Jensen, 2006, Is visceral fat involved in the pathogenesis of the metabolic syndrome?, Human model Obes (Silver Spring), 14, 20S, 10.1038/oby.2006.278

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889

Adams, 2004, Ceramide content is increased in skeletal muscle from obese insulin-resistant humans, Diabetes, 53, 25, 10.2337/diabetes.53.1.25

Chavez, 2005, Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling, J Biol Chem, 280, 20148, 10.1074/jbc.M412769200

Kelley, 2001, Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance, Diabetes Care, 24, 933, 10.2337/diacare.24.5.933

Nadler, 2001, Please pass the chips: genomic insights into obesity and diabetes, J Nutr, 131, 2078, 10.1093/jn/131.8.2078

Grill, 1999, Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects, Diabetologia, 42, 15, 10.1007/s001250051106

Williams, 2001, Study of distribution and factors affecting syphilis epidemic among inner-city minorities of Baltimore, Public Health, 115, 387, 10.1016/S0033-3506(01)00484-X

Krause, 1991, Syphilis during 1900-1910: similarities to present-day AIDS, Allergy Proc, 12, 127, 10.2500/108854191779011756

Bays, 2002, Anti-obesity drug development, Expert Opin Investig Drugs, 11, 1189, 10.1517/13543784.11.9.1189

Bray, 2004, Medical consequences of obesity, J Clin Endocrinol Metab, 89, 2583, 10.1210/jc.2004-0535

Kushner, 2003, Assessment of the obese patient, Endocrinol Metab Clin North Am, 32, 915, 10.1016/S0889-8529(03)00068-9

Munoz, 2007, Why patients seek bariatric surgery: a qualitative and quantitative analysis of patient motivation, Obes Surg, 17, 1487, 10.1007/s11695-008-9427-9

Cawley, 2007, Predicting complications after bariatric surgery using obesity-related co-morbidities, Obes Surg, 17, 1451, 10.1007/s11695-008-9422-1

WHO Expert Consultation, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3

Bays, 2005, Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything, Expert Rev Cardiovasc Ther, 3, 393, 10.1586/14779072.3.3.393

Bays, 2006, High Prevalence of Misdiagnosis of the Metabolic Syndrome in a Self-Reported Survey: Possible Confusion with having ‘a Metabolism Problem’